Thermedical® is a pioneering medical device company based in Waltham, Massachusetts. They are focused on developing a proprietary thermal ablation therapy that has the ability to treat significantly larger tissue volumes using a single device compared to conventional technology. Their main areas of focus are the treatment and cure of Ventricular Tachycardia (VT), which can lead to sudden cardiac arrest, and the treatment of various soft tissue conditions.

Thermedical's revolutionary Thermedical Ablation System utilizes Saline-Enhanced Radio Frequency (SERF) energy to efficiently and predictably ablate large volumes of tissue. This system, along with the Needle, is 510(k) cleared for the coagulation and ablation of soft tissue during percutaneous, laparoscopic, and intraoperative surgical procedures. In addition, Thermedical is currently in the process of developing a smaller catheter-based delivery system called Durablate™, which is specifically designed for the treatment of VT.

With their innovative technology and commitment to improving patient outcomes, Thermedical is revolutionizing the field of thermal ablation therapy, providing new hope for patients with VT and soft tissue conditions